Relugolix?

Relugolix is an oral gonadotropin (GnRH) receptor antagonist used to treat advanced endometriosis and uterine fibroids (symptomatic leiomyomas) (market availability depends on country). It lowers estrogen by suppressing pituitary signaling, which is why it helps symptoms like pelvic pain and heavy bleeding.

What it does (mechanism)

• Blocks GnRH receptors in the pituitary
• Decreases LH/FSH release
• Leads to reduced ovarian estrogen (endometriosis) and reduction in fibroid-related hormone drive

Common uses

• Endometriosis: helps reduce pain and endometriosis-related symptoms
• Uterine fibroids: helps reduce heavy menstrual bleeding and fibroid size in some patients

Side effects (common)

• Hot flashes
• Headache
• Nausea
• Fatigue
• Musculoskeletal pain/joint aches
• Possible vaginal dryness or changes in vaginal bleeding patterns (especially in fibroid/endometriosis contexts)

Important warnings / cautions

• Bone mineral density (BMD) decrease can occur (like with other hypoestrogenic therapies), especially with longer use—your clinician may monitor or add strategies to protect bone health.
• Pregnancy prevention is important: relugolix can harm an ongoing pregnancy. Use appropriate contraception if relevant.
• It may be less compatible with certain hormonal contraceptives depending on regimen—your prescriber will advise the safest approach.

Drug interactions

Relugolix can interact with strong CYP3A inducers or inhibitors (these can raise or lower relugolix levels). Tell your clinician/pharmacist about all meds and supplements.

If you tell me what you’re using it for (endometriosis vs fibroids) and your dose/country, I can give more specific guidance—like expected timeline of symptom relief, what bleeding changes are normal, and key monitoring.